Triple-negative breast cancer (TNBC) is a subtype of breast cancer that accounts for 10–15% of breast cancers, characterized by a lack of estrogen receptor (ER), progesterone receptor (PR), and an expression of low levels of human epidermal growth factor 2 (HER2) [1,2]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.